Sugi Predict

Sugi Predict / Compounds / Ethyl Acetate

Ethyl Acetate

Ethyl Acetate

SCHEMBL2533445

CCCC(CC)CC(=O)OCC.CCOC(C)=O

nearest known ligand 0.50

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 8/20 0.50
▸ HSD17B10 Q99714 2/20 0.50
▸ LMNA P02545 1/20 0.50
▸ MGAM O43451 1/20 0.39
▸ GAA P10253 1/20 0.39
▸ SI P14410 1/20 0.39
▸ MGAM2 Q2M2H8 1/20 0.39
▸ RECQL P46063 1/20 0.38
▸ TSHR P16473 5/20 0.38
▸ CYP3A4 P08684 3/20 0.38
▸ TDP1 Q9NUW8 2/20 0.38
▸ ATM Q13315 1/20 0.38
▸ FAAH O00519 1/20 0.37
▸ TRPA1 O75762 1/20 0.36
▸ ALOX15 P16050 2/20 0.35
▸ CHRM1 P11229 1/20 0.34
▸ ADORA1 P30542 1/20 0.34
▸ F2 P00734 1/20 0.33
▸ F10 P00742 1/20 0.33
▸ L3MBTL1 Q9Y468 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2959866 0.93 MGAM (0.44) ALDH1A1HSD17B10LMNAMGAMGAA
Ethyl Acetate SCHEMBL1643383 0.90 ALDH1A1 (0.47) ALDH1A1HSD17B10LMNAMGAMGAA
SCHEMBL4075525 0.85 ALDH1A1 (0.50) ALDH1A1HSD17B10LMNAMGAMGAA
SCHEMBL235094 0.85 MGAM (0.48) ALDH1A1HSD17B10LMNAMGAMGAA
SCHEMBL8334750 0.81 CYP3A4 (0.56) ALDH1A1HSD17B10LMNAMGAMGAA
SCHEMBL1456370 0.80 MGAM (0.52) ALDH1A1HSD17B10LMNAMGAMGAA
SCHEMBL234553 0.80 MGAM (0.52) ALDH1A1HSD17B10LMNAMGAMGAA
SCHEMBL7221506 0.80 TSHR (0.55) ALDH1A1LMNATSHRCYP3A4TDP1
SCHEMBL27579319 0.80 TSHR (0.50) ALDH1A1LMNAMGAMGAASI
SCHEMBL15187255 0.79 MGAM (0.43) ALDH1A1HSD17B10LMNAMGAMGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3456710-B1 NOVEL PROSTAGLANDIN DERIVATIVE AGC INC (JP) 2021-06-30 — — EP disclosed
US-20200297700-A1 BICYCLIC COMPOUND, PRODUCTION AND USE THEREOF TOBIRA THERAPEUTICS INC (US) 2020-09-24 — — US disclosed
US-10494338-B2 Prostaglandin derivative AGC Inc. (JP) 2019-12-03 — — US disclosed
US-20190135743-A1 NOVEL PROSTAGLANDIN DERIVATIVE AGC Inc. (JP) 2019-05-09 — — US disclosed
EP-3456710-A1 NOVEL PROSTAGLANDIN DERIVATIVE AGC INC. (JP) 2019-03-20 — — EP disclosed
US-10155731-B2 Nitrogen-containing saturated heterocyclic compound MITSUBISHI TANABE PHARMA CORPORATION (JP) 2018-12-18 — — US disclosed
US-20180207153-A1 UREA DERIVATIVE OR PHARMACOLOGICALLY ACCEPTABLE SALT THEREOF KYORIN PHARMACEUTICAL CO., LTD. (JP) 2018-07-26 — — US disclosed
EP-2933248-B1 NOVEL RENIN INHIBITOR MITSUBISHI TANABE PHARMA CORP (JP) 2018-01-31 — — EP disclosed
EP-2687518-B1 NITROGEN-CONTAINING SATURATED HETEROCYCLIC COMPOUND MITSUBISHI TANABE PHARMA CORP (JP) 2017-11-01 — — EP disclosed
US-9556159-B2 Renin inhibitor MITSUBISHI TANABE PHARMA CORPORATION (JP) 2017-01-31 — — US disclosed
WO-2005063729-A1 3-(4-BENZYLOXYPHENYL)PROPANOIC ACID DERIVATIVES TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2005-07-14 — — WO disclosed
US-20040127574-A1 Aminoethanol derivatives TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2004-07-01 — — US disclosed
EP-1362846-A1 AMINOETHANOL DERIVATIVES Takeda Chemical Industries, Ltd. (JP) 2003-11-19 — — EP disclosed
EP-0767790-B1 CONDENSED IMIDAZOLE COMPOUNDS, THEIR PRODUCTION AND USE TAKEDA CHEMICAL INDUSTRIES LTD (JP) 2001-12-12 — — EP disclosed
EP-0900210-A1 ANTIVIRALLY ACTIVE HETEROCYCLIC AZAHEXANE DERIVATIVES Novartis AG (CH) 1999-03-10 — — EP disclosed
US-5840732-A ANTIDIABETIC AGENTS, AUTOIMMUNE DISEASES OR IMMUNOSUPPRESSANTS TAKEDA CHEMICAL INDUSTRIES LTD. (JP) 1998-11-24 — — US disclosed
WO-1997046514-A1 PROCESS FOR THE PREPARATION OF HYDRAZINE DERIVATIVES USEFUL AS INTERMEDIATES FOR THE PREPARATION OF PEPTIDE ANALOGUES NOVARTIS AG (CH) 1997-12-11 — — WO disclosed
WO-1997040029-A1 ANTIVIRALLY ACTIVE HETEROCYCLIC AZAHEXANE DERIVATIVES NOVARTIS AG (CH) 1997-10-30 — — WO disclosed
US-4906663-A 6-fluoroprostaglandins ASAHI GLASS COMPANY, LTD. (JP) 1990-03-06 — — US disclosed
EP-0312055-A2 6-Fluoroprostaglandins ASAHI GLASS COMPANY LTD. (JP) 1989-04-19 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10494338-B2 Prostaglandin derivative PTGIR, PTGIS, PTGS1 ALDH1A1 1221/4885HSD17B10 703/4885LMNA 2523/4885
US-20040127574-A1 Aminoethanol derivatives CETP, LCAT, MTTP ALDH1A1 783/4885HSD17B10 151/4885LMNA 2989/4885
US-10155731-B2 Nitrogen-containing saturated heterocyclic compound REN, AGTR1, AGTR2 ALDH1A1 2704/4885HSD17B10 1304/4885LMNA 2965/4885
US-20190135743-A1 NOVEL PROSTAGLANDIN DERIVATIVE PTGIR, PTGIS, PTGER1 ALDH1A1 1005/4885HSD17B10 664/4885LMNA 2750/4885
US-20180207153-A1 UREA DERIVATIVE OR PHARMACOLOGICALLY ACCEPTABLE SALT THEREOF FPR1, FPR2, SAAL1 ALDH1A1 2705/4885HSD17B10 3807/4885LMNA 2803/4885
US-20200297700-A1 BICYCLIC COMPOUND, PRODUCTION AND USE THEREOF CCR5, CCR1, CCR2 ALDH1A1 2749/4885HSD17B10 2532/4885LMNA 4285/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.